FR2112390B1 - - Google Patents

Info

Publication number
FR2112390B1
FR2112390B1 FR7139126A FR7139126A FR2112390B1 FR 2112390 B1 FR2112390 B1 FR 2112390B1 FR 7139126 A FR7139126 A FR 7139126A FR 7139126 A FR7139126 A FR 7139126A FR 2112390 B1 FR2112390 B1 FR 2112390B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7139126A
Other versions
FR2112390A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2112390A1 publication Critical patent/FR2112390A1/fr
Application granted granted Critical
Publication of FR2112390B1 publication Critical patent/FR2112390B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/27—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7139126A 1970-11-02 1971-10-29 Expired FR2112390B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8630370A 1970-11-02 1970-11-02
US16744671A 1971-07-29 1971-07-29

Publications (2)

Publication Number Publication Date
FR2112390A1 FR2112390A1 (fr) 1972-06-16
FR2112390B1 true FR2112390B1 (fr) 1975-08-01

Family

ID=26774597

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7139126A Expired FR2112390B1 (fr) 1970-11-02 1971-10-29

Country Status (6)

Country Link
BE (1) BE774709A (fr)
DE (1) DE2154309C3 (fr)
FR (1) FR2112390B1 (fr)
GB (1) GB1324737A (fr)
HK (1) HK57378A (fr)
NL (1) NL174142C (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971826A (en) * 1972-07-13 1976-07-27 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US3974213A (en) * 1972-07-13 1976-08-10 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
US4011262A (en) * 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
NO143741C (no) * 1972-07-13 1981-04-08 Pfizer Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
DD118856A5 (fr) * 1972-11-08 1976-03-20
US3968144A (en) * 1973-05-21 1976-07-06 The Upjohn Company 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs
US3966795A (en) * 1973-05-21 1976-06-29 The Upjohn Company 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs
US4005115A (en) * 1974-01-07 1977-01-25 The Upjohn Company Phenyl-substituted prostaglandin-A type analogs
US4001286A (en) * 1974-01-07 1977-01-04 The Upjohn Company Phenyl-substituted prostaglandin-β-type anologs
US4328355A (en) * 1976-12-27 1982-05-04 G. D. Searle & Co. Prostaglandin derivatives having aryl, hydroxyl, and alkynyl functions in one side chain
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE227576T1 (de) * 1988-09-06 2002-11-15 Pharmacia Ab Prostaglandinderivate zur behandlung des grünen stars oder einer okularen hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5223537A (en) * 1991-07-23 1993-06-29 Kabi Pharmacia Ab Method and composition for treatment of gastric and duodenal disorders
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Also Published As

Publication number Publication date
BE774709A (fr) 1972-05-02
DE2154309A1 (de) 1972-05-04
GB1324737A (en) 1973-07-25
HK57378A (en) 1978-10-06
FR2112390A1 (fr) 1972-06-16
NL174142C (nl) 1984-05-01
DE2154309B2 (de) 1980-11-06
NL7115049A (fr) 1972-05-04
DE2154309C3 (de) 1981-06-19

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
FR2112390B1 (fr)
ATA96471A (fr)
AU1146470A (fr)
AU1833270A (fr)
AU1716970A (fr)
AR195465A1 (fr)
AU1881070A (fr)
AU1943370A (fr)
AU1603270A (fr)
AU1689770A (fr)
AU1247570A (fr)
AU1235770A (fr)
AU1841070A (fr)
AU1872870A (fr)
AU2131570A (fr)
AU2144270A (fr)
AU1789870A (fr)
AU1591370A (fr)
AU1918570A (fr)
AU1086670A (fr)
AU1083170A (fr)
AU1064870A (fr)
AU1879170A (fr)
AU1004470A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse